Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Reflect ScientificRSCF +6.26% PS Ratio is 5.35 as of Jul. 15, 2026, which is 69% above its 10-year median of 3.16. The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Reflect Scientific ranks worse than 71.06% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Reflect Scientific's share price is $0.04277.
Reflect Scientific's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $0.01. Hence, Reflect Scientific's PS Ratio for today is 5.35.
Good Sign:
Reflect Scientific Inc stock PS Ratio (=5.03) is close to 1-year low of 5.03.
The historical rank and industry rank for Reflect Scientific's PS Ratio or its related term are showing as below:
RSCF'
s PS Ratio Range Over the Past 10 Years
Min: 1.43 Med: 3.16 Max: 114.05
Current: 5.34
During the past 13 years, Reflect Scientific's highest PS Ratio was 114.05. The lowest was 1.43. And the median was 3.16.
RSCF's PS Ratio is ranked worse than 71.06% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.88
vs RSCF: 5.34
Reflect Scientific Inc revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Reflect Scientific was 50.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -26.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -5.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -1.00% per year.
During the past 13 years, Reflect Scientific's highest 3-Year average Revenue per Share Growth Rate was 47.50% per year. The lowest was -45.80% per year. And the median was -11.10% per year.
Back to Basics: PS Ratio
Reflect Scientific (OTCPK:RSCF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Reflect Scientific PS Ratio Related Terms
Reflect Scientific PS Ratio Historical Data
* Premium members only.
The historical data trend for Reflect Scientific's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Reflect Scientific's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reflect Scientific PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's PS Ratio distribution charts can be found below:
* The bar in red indicates where Reflect Scientific's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Reflect Scientific's Share Price of today is $0.04277. Reflect Scientific's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Reflect Scientific (RSCF) has a PS Ratio of 5.35 as of Jul. 15, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Reflect Scientific and its competitors. This is 69% above median its historical median of 3.16. Over the past decade, Reflect Scientific's PS Ratio has ranged from 1.43 to 114.05. According to the industry distribution chart, Reflect Scientific ranks #572 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 71.1%.
Is Reflect Scientific's PS Ratio too high?
Reflect Scientific's current PS Ratio of 5.35 is 69% above median its 10-year median of 3.16. Over the past 10 years, this metric has ranged from a low of 1.43 to a high of 114.05. The Medical Devices & Instruments industry median PS Ratio is 2.88. Reflect Scientific's value of 5.35 is 85.8% above this industry median. Based on the distribution chart, Reflect Scientific ranks #572 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Reflect Scientific's PS Ratio compare to NXGL and LUCY?
According to the Medical Devices & Instruments industry distribution chart, Reflect Scientific ranks #572 out of 805 companies for PS Ratio. This places Reflect Scientific in the lower half of its industry. The industry median PS Ratio is 2.88. Reflect Scientific's value of 5.35 is 85.8% above this benchmark. Historically, Reflect Scientific's own PS Ratio has ranged from 1.43 to 114.05 over the past decade. While the company's 10-year median is 3.16 vs. the industry median of 2.88, Reflect Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.88, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Reflect Scientific's current PS Ratio of 5.35 is 85.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Reflect Scientific and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reflect Scientific's current PS Ratio is 5.35, which is 69% above median its own 10-year median of 3.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reflect Scientific stock overvalued right now?
Reflect Scientific (RSCF) has a current PS Ratio of 5.35. The current PS Ratio is 5.35, which is 69% above median its 10-year median of 3.16 and 85.8% above the Medical Devices & Instruments industry median of 2.88. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Reflect Scientific (RSCF), the current PS Ratio is 5.35 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The group's customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management, universities, government and private sector research facilities, and chemical and industrial companies. Its growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers, and refrigerated transportation in addition to supplying OEM products to the life sciences industry. The group's products are Cryometrix, GCFerrules, and Visacon. It recognizes revenue from the sale of scientific equipment for the life sciences and manufacturing industries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RSCF has been successfully added to your 
